PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25924F0437Carvykti — Janssen Biotech, Inc

Janssen Biotech, Inc holds $1.5M across 46 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award under parent 36F79719D0217. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jul 30, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 19 (36C259)

Awarding office

Janssen Biotech, Inc

Recipient

Jul 30, 2024

PoP end

$360K

Obligated

$360K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Janssen Biotech, Inc — $90

Contract facts

Federal

Contract number36C25924F0437

Also listed as36C259-24-F-0437

Also listed as36F79719D0217-36C25924F0437

AgencyNetwork Contract Office 19 (36C259)

Awarding officeNetwork Contract Office 19 (36C259)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentJanssen Biotech, Inc

CAGE0MJM1

UEINVYMGFA53MN7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79719D0217

Place of performanceHORSHAM PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJul 18, 2024

PoP end (current)Jul 30, 2024

Obligated$360K

Current value$360K

Potential value$360K

CARVYKTI is a federal award for Network Contract Office 19 (36C259) held by Janssen Biotech, Inc. Estimated value $360K ($360K obligated). Current period of performance ends Jul 30, 2024. Last award drew 1 bidder. Place of performance: HORSHAM PA.

Recompete timing

Public

● Past PoP end (752 days ago)

Current PoP ended Jul 30, 2024 (752 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Janssen Biotech, Inc — $1.5M obligated across 46 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$1.5M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

36C25926F0264

EMERGENCY PHARMACY CARVYKTI FOR RMR

$385K

Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25924F0437?

36C25924F0437 (Carvykti) is a Network Contract Office 19 (36C259) award with a potential value of $360K, currently held by Janssen Biotech, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C259-24-F-0437?

36C259-24-F-0437 is the dashed form of PIID 36C25924F0437 (Carvykti), held by Janssen Biotech, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25924F0437?

Network Contract Office 19 (36C259) awarded 36C25924F0437 to Janssen Biotech, Inc (potential $360K).

Who is the incumbent on 36C25924F0437?

Janssen Biotech, Inc is the incumbent with $1.5M across 46 related awards in SCOUT’s public footprint. The current period of performance ends Jul 30, 2024.

When does Janssen Biotech, Inc’s 36C25924F0437 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 11, 2026 · refreshed monthlyLatest procurement action Jul 18, 2024